(6Z)-6-{[(1Z)-1-{[(1R)-1-Carboxy-2-methyl-2-propen-1-yl]imino}-1-hydroxy-3-sulfanyl-2-propanyl]imino}-6-hydroxynorleucine
DB02582ExperimentalSmall molecule
(6Z)-6-{[(1Z)-1-{[(1R)-1-Carboxy-2-methyl-2-propen-1-yl]imino}-1-hydroxy-3-sulfanyl-2-propanyl]imino}-6-hydroxynorleucine: Overview.
![Chemical structure of (6Z)-6-{[(1Z)-1-{[(1R)-1-Carboxy-2-methyl-2-propen-1-yl]imino}-1-hydroxy-3-sulfanyl-2-propanyl]imino}-6-hydroxynorleucine](/structures/DB02582/thumb.svg)
- Formula / weight
- C14H23N3O6S ยท 361.414 g/mol (avg)
Resolves to
Compound
Structure
InChIKey
BGZJEMYSINIAHS-NWGYLPEXSA-NSMILES[H][C@@](N=C(O)C(CS)N=C(O)CCCC(N)C(O)=O)(C(C)=C)C(O)=OWhich companies are running trials of (6Z)-6-{[(1Z)-1-{[(1R)-1-Carboxy-2-methyl-2-propen-1-yl]imino}-1-hydroxy-3-sulfanyl-2-propanyl]imino}-6-hydroxynorleucine, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account